Animal experiments reveal ezetimibe can reduce the fasting insulin and improve the high-lipid induced impaired glucose tolerance (IGT) in diabetic rats with insulin resistance, but the specific mechanism is still unclear [4]. This evidence concerns the gene INS and Insulin resistance.